HIV Infection Clinical Trial
Official title:
The Causal Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
HSPOT is a cluster-randomized trial designed to determine whether HIV self-tests are acceptable and improve HIV testing rates and HIV status knowledge among female sex workers in Kampala, Uganda. This study will determine whether directly giving participants an HIV self-test or giving them a coupon to collect a test at a drug store or clinic improves outcomes compared to standard of care.
Although Uganda has a generalized HIV epidemic, with approximately 7.4% of adults aged 15 to
49 living with HIV, the epidemic remains even more highly concentrated in key populations,
including female sex workers (FSW). A particular concern for FSW is access to healthcare
services, including HIV testing services. FSW face significant barriers to accessing
healthcare. In other settings, evidence has suggested that stigma is a significant barrier to
FSW seeking HIV testing. It is likely that similar mechanisms exist in Uganda. Evidence from
Uganda has indicated that complex multilevel factors, such as stigmatization and harassment,
contribute to vulnerability among FSW. User-controlled HIV prevention interventions that lead
to empowerment of FSW may therefore be a powerful way to address the HIV epidemic in this key
population.
Oral HIV self-testing consists of an oral swab kit that allows individuals to test for HIV in
the privacy of their own homes whenever they want. The ease of use of HIV self-testing, that
it can be done at any time, and that is completely private may make it an attractive
alternative to currently-available HIV testing mechanisms for FSW in Uganda. HIV self-testing
has generally been shown to be acceptable in a variety of populations, however evidence
related to its uptake and acceptability remain sparse, especially among key populations and
in Sub-Saharan Africa. This research will provide rigorous evidence of the uptake and
efficacy of HIV self-testing for this population.
HSPOT was designed to determine whether either direct distribution of HIV self-test kits via
peer educators or distribution of HIV self-tests via coupons that participants can use to
collect kits at collection points such as drug stores or health posts leads to better
coverage of HIV testing and better awareness of HIV status. HSPOT is a cluster-randomized
trial in which peer educators recruit a small group of FSW participants, and the peer
educator group is randomized to one of three study arms: 1) direct distribution of test kits,
2) fixed distribution of test kits, or 3) referral to standard of care HIV testing. The
primary outcome is HIV testing in the past month measured at one and four months after the
first peer educator visit (when the test kits or coupons are distributed in the intervention
arms).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02135419 -
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
|
Phase 3 | |
Active, not recruiting |
NCT02663856 -
My Smart Age With HIV: Smartphone Self-assessment of Frailty
|
||
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Completed |
NCT02921516 -
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings
|
N/A | |
Completed |
NCT02659306 -
Metformin Immunotherapy in HIV Infection
|
Phase 1 | |
Completed |
NCT02663869 -
Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
|
||
Completed |
NCT02564341 -
Targeting Effective Analgesia in Clinics for HIV - Intervention
|
N/A | |
Active, not recruiting |
NCT02302950 -
A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
|
N/A | |
Completed |
NCT01830595 -
Lactoferrin Treatment in HIV Patients
|
Phase 2 | |
Completed |
NCT01852942 -
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
Phase 2 | |
Terminated |
NCT02109224 -
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
|
Phase 1 | |
Completed |
NCT02269605 -
Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
|
Phase 1 | |
Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
Completed |
NCT01946217 -
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
|
N/A | |
Completed |
NCT02525146 -
Birmingham Access to Care Study
|
N/A | |
Completed |
NCT02118168 -
Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
|
N/A | |
Completed |
NCT02527135 -
Text Messaging to Improve HIV Testing Among Young Women in Kenya
|
N/A | |
Active, not recruiting |
NCT02602418 -
Neural Correlates of Working Memory Training for HIV Patients
|
N/A | |
Completed |
NCT01702974 -
Immune Reconstitution in HIV Disease (IREHIV)
|
Phase 2 | |
Completed |
NCT01680094 -
Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
|
Phase 1/Phase 2 |